We are live on ! Find out more
O

OrbiMed Portfolio holdings

AUM $4.59B
1-Year Est. Return 125.28%
This Fund
S&P 500
This Quarter Est. Return
+30.69%
1 Year Est. Return
+125.28%
3 Year Est. Return
+334.72%
5 Year Est. Return
+344.07%
10 Year Est. Return
+2,748.76%
AUM
$5.45B
AUM Growth
+$454M
Cap. Flow
-$312M
Cap. Flow %
-5.73%
Top 10 Hldgs %
39.03%
Holding
130
New
20
Increased
22
Reduced
29
Closed
17

Top Buys

1
AVBP icon
ArriVent BioPharma
AVBP
+$61.1M
2
CYTK icon
Cytokinetics
CYTK
+$52.8M
3
ESPR icon
Esperion Therapeutics
ESPR
+$33.3M
4
MRK icon
Merck
MRK
+$32.2M
5
QTTB icon
Q32 Bio
QTTB
+$31M

Top Sells

1
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$147M
2
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
+$93.5M
3
UTHR icon
United Therapeutics
UTHR
+$84.9M
4
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
+$71.7M
5
SWTX
SpringWorks Therapeutics
SWTX
+$69.9M

Sector Composition

1 Healthcare 99.34%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHGE icon
101
BiomX
PHGE
$2.14M
$2.03M 0.04%
23,777
– –
CMMB
102
Chemomab Therapeutics
CMMB
$11.4M
$1.75M 0.03%
560,319
– –
KZR
103
DELISTED
Kezar Life Sciences
KZR
$1.74M 0.03%
192,700
– –
VIGL
104
DELISTED
Vigil Neuroscience
VIGL
$1.53M 0.03%
448,891
– –
DVAX
105
DELISTED
Dynavax Technologies
DVAX
$1.41M 0.03%
+113,500
New +$1.48M
CALC icon
106
CalciMedica
CALC
$12M
$1.24M 0.02%
297,380
– –
LSB
107
DELISTED
LakeShore Biopharma
LSB
$1.1M 0.02%
153,443
-170,188
-53% -$867K
AFIB
108
DELISTED
Acutus Medical Inc
AFIB
$498K 0.01%
2,648,386
– –
LYEL icon
109
Lyell Immunopharma
LYEL
$346M
$445K 0.01%
+9,975
New +$427K
OMIC
110
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$278K 0.01%
18,023
– –
XERS icon
111
Xeris Biopharma Holdings
XERS
$1.47B
$178K ﹤0.01%
+80,420
New +$208K
AGIO icon
112
Agios Pharmaceuticals
AGIO
$2.37B
– –
-45,000
Closed -$1M
ALNY icon
113
Alnylam Pharmaceuticals
ALNY
$37B
– –
-79,400
Closed -$15.2M
CLDX icon
114
Celldex Therapeutics
CLDX
$3.04B
– –
-58,800
Closed -$2.33M
GILD icon
115
Gilead Sciences
GILD
$164B
– –
-100,000
Closed -$8.1M
HUM icon
116
Humana
HUM
$48.9B
– –
-109,900
Closed -$50.3M
ILMN icon
117
Illumina
ILMN
$28.2B
– –
-31,148
Closed -$4.22M
IOVA icon
118
Iovance Biotherapeutics
IOVA
$2.06B
– –
-4,707,458
Closed -$38.3M
PFE icon
119
Pfizer
PFE
$141B
– –
0
– –
QURE icon
120
uniQure
QURE
$2.81B
– –
-1,347,900
Closed -$9.13M
RAPT
121
DELISTED
RAPT Therapeutics
RAPT
– –
-35,177
Closed -$6.99M
RCUS icon
122
Arcus Biosciences
RCUS
$3.53B
– –
-117,000
Closed -$2.23M
UTHR icon
123
United Therapeutics
UTHR
$22.6B
– –
-386,100
Closed -$84.9M
RCM
124
DELISTED
R1 RCM Inc. Common Stock
RCM
– –
-4,803,200
Closed -$50.8M
FUSN
125
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
– –
-3,122,770
Closed -$30M
2 3 4
5
6

Similar funds

CGI
Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $4.57B AUM 32.26% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
ECM
Evergreen Capital Management Bellevue, Washington $4.61B AUM 25.58% 1-Year Est. Return